21.03.2012 12:35 Uhr, Quelle: Wallstreet online

The Road Ahead for Biosimilars in Europe, Says Frost & Sullivan

LONDON, March 21, 2012 /PRNewswire/ - Huge Market Opportunity from Impending Patent Expiry of Blockbuster Biologics The expiration of patents and other intellectual property rights of biological innovators over the next decade opens the …

Weiterlesen bei Wallstreet online